RPL10P14

Across TCGA pan-cancer cohorts, RPL10P14 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated RPL10P14 data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher RPL10P14 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPL10P14 expression acts as an unfavorable survival marker, although some lineages such as BLCA and MESO show a favorable association.

READ, BLCA, and STAD are the cancer types where RPL10P14 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	OS	Quartile	III,IV	0.227	0.790	.001	17	view →
BLCA	DFS	Tertile	III,IV	0.524	0.297	.029	15	view →
STAD	DFS	Quartile	II,III,IV	0.577	0.740	.032	13	view →
MESO	OS	Quartile	All	0.758	0.319	.029	12	view →
CHOL	DFS	Tertile	II,III,IV	1.000	0.147	.041	9	view →
KIRP	OS	Quartile	II,III,IV	0.603	0.889	.011	5	view →
LUSC	OS	Tertile	II,III,IV	0.577	0.851	.018	5	view →
GBM	DFS	Median	All	0.392	0.192	.005	3	view →
KICH	DFS	Quartile	II,III,IV	0.476	0.879	.035	2	view →
ESCA	OS	Tertile	II,III,IV	0.442	0.631	.044	2	view →
SARC	OS	Tertile	All	0.785	0.874	.035	2	view →
PRAD	DFS	Tertile	All	0.954	0.907	.039	2	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

RPL10P14–READ (OS)

Open the READ breakdown →